Search

everythinglearnresearchcommunity

for

Search:↓

Tiny lipid particles loaded with a hormone gather in hair follicles, which may help treat hair loss.

Hirsutism treatments can slow new hair growth, but existing hair needs removal, and eflornithine helps reduce hair growth.

Applying estradiol to skin causes local changes but not cancer.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Laser and Eflornithine are more effective for hair removal than traditional methods.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

The combination treatment didn't work better than minoxidil alone and caused more menstrual issues.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Special fiber materials boost the healing properties of certain stem cells.

Laser device increases hair density, safe for treating hair loss in men and women.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Reduced AR gene methylation may cause early pubic hair growth in girls.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Flutamide reduces hair growth better but has more side effects.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.